Cat. No. | Product name | CAS No. |
DC9152 |
Benazepril Hydrochloride
Benazepril hydrochloride, an angiotensin converting enzyme inhibitor, which is a medication used to treat high blood pressure. |
86541-74-4 |
DC8895 |
benzbromaron
Featured
Benzbromarone is a highly effective and well tolerated non-competitive inhibitor of xanthine oxidase, used as an uricosuric agent, used in the treatment of gout. |
3562-84-3 |
DC11105 |
Umibecestat
Featured
beta-secretase inhibitor. |
1387560-01-1 |
DC7373 |
Betrixaban
Featured
Betrixaban (PRT-054021) is a highly potent, selective, and orally efficacious factor Xa inhibitor with IC50 of 1.2 nM(inhibition of Factor 10a). |
330942-05-7 |
DC11389 |
BI 409306
Featured
BI 409306 is an inhibitor of phosphodisterase 9A(PDE9A). |
1189767-28-9 |
DC11842 |
BI 135585
BI 135585 (BI-135585, BI135585) is a potent, selective, orally active 11β-HSD1 inhibitor with IC50 of 4.3 nM and 53 nM in human adipocytes and primary human adipose tissue, respectively. |
1114561-85-1 |
DC10404 |
BIA 10-2474
Featured
BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions. |
1233855-46-3 |
DCAPI1112 |
BIBR 953(Dabigatran)
Featured
BIBR 953 (Dabigatran, Pradaxa) is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate. |
211914-51-1 |
DC1010 |
BIBR-1048 (Dabigatran etexilate)
Featured
BIBR-1048 (Dabigatran) is an anticoagulant from the class of the direct thrombin inhibitors. |
211915-06-9 |
DC11761 |
BMS-816336
A novel potent, selective, orally active human 11β-HSD1 inhibitor with IC50 of 3.0 nM. |
1009583-20-3 |
DC10131 |
BMS-986205(Linrodostat)
Featured
BMS-986205 is an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic activity, alone and in combination with nivolumab in advanced cancers in a phase 1/2a trial |
1923833-60-6 |
DC8446 |
BRD7116
Featured
BRD7116 competitively binds to bacterial DNA gyrase, exhibits an EC50 of 200 nM for LSCe cells, with cell-non-autonomous anti-leukemia activity. |
329059-55-4 |
DC8089 |
BVT 2733(BVT.2733)
Featured
BVT 2733 is a selective 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor,protecting osteoblasts against endogenous glucocorticoid induced dysfunction. |
376640-41-4 |
DC8278 |
BVT-14225
Featured
BVT 14225 is a new selective 11b-HSD1 inhibitor, it belongs to a class of arylsulfonamidothiazoles with in vitro and in vivo antidiabetic effects |
376638-65-2 |
DC12041 |
BW-A 78U
Featured
BW-A 78U is a PDE4 inhibitor with an IC50 of 3 μM. |
101155-02-6 |
DC9528 |
C75 (trans)
Featured
C75 trans is the trans form of C75; C75 is a potent fatty-acid synthase(FASN) inhibitor with IC50 of 35.4 μM(LNCaP cell Proliferation inhibition). |
191282-48-1 |
DC7697 |
CA-074-Me
Featured
CA-074 Me is a selective and cell-permeable inhibitor of cathepsin B. |
147859-80-1 |
DC8975 |
Captopril
Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE). |
62571-86-2 |
DC8705 |
Carbosulfan
Carbosulfan inhibited relatively potently CYP3A4 and moderately CYP1A1/2 and CYP2C19 in pooled HLM (human livers). Carbosulfan activation is predominantly catalyzed in humans by CYP3A4. |
55285-14-8 |
DC9384 |
Carboxypeptidase G2 (CPG2) Inhibitor
Featured
Carboxypeptidase G2 (CPG2) Inhibitor is a novel Carboxypeptidase G2 (CPG2) Inhibitor, Antitumor agents. |
192203-60-4 |
DCAPI1119 |
Cathepsin Inhibitor 1
Cathepsin Inhibitor 1 is an inhibitor of Cathepsin (L, L2, S, K, B) with pIC50 of 7.9, 6.7, 6.0, 5.5 and 5.2, respectively. |
225120-65-0 |
DC11709 |
CB-1158
CB-1158 (INCB-01158) is a potent, selective, oral available Arginase inhibitor with IC50 of 98 nM. |
2095732-06-0 |